Indian Government is now looking to buy delamanid for the first time from Otsuka.

Doctors, scientists, and TB survivors invited to the World Lung Health Conference organised by The International Union Against Tuberculosis and Lung Disease (The Union) in Hyderabad stayed away from the event citing the high registration fees.

One in four patients affected by Tuberculosis (TB) has to spend out of his/her own pocket to access treatment, which should otherwise be anyway available for free.

Crucial anti-Tuberculosis (TB) drug Delamanid will now be available across India. Until currently, its supply was restricted to seven States.

The roll-out of crucial anti-tuberculosis drug, Bedaquiline is slow because of a substantial lack of digital electrocardiogram (ECG) machines on field.

India gets doses of Delamanid from USAID.

New Delhi, September 16 - The Centre’s long-pending plan to combine tuberculosis (TB) and human immunodeficiency virus (HIV) control programmes may never happen.

Dr Soumya Swaminathan, Secretary of the Department of Health Research in India’s Ministry of Health & Family Welfare and Director General of the Indian Council of Medical Research (ICMR), speaks to DNA on ICMR’s ongoing study on cellphone tower radiation, dedication to eliminate leprosy and its future plans.

A study, jointly conducted by Medecins Sans Frontiers (MSF) and Lilavati Hospital in Mumbai, has shown that some anti-tuberculosis drugs can have adverse effects on the eye, and can even lead to compromised vision in patients.

Interview with Dr Mario Raviglione, Director, World Health Organization's Global Tuberculosis Programme since 2003. Dr Raviglione has worked on TB control issues for two decades. In conversation with Maitri Porecha at the 44th Union World Conference of Lung Health in Paris, France, Dr Raviglione talks about challenges India faces in tackling the dreaded Tuberculosis scourge.